Fibroblast growth factor 2 inhibits myofibroblastic activation of valvular interstitial cells.

Heart valve disease is a growing problem worldwide. Though very common in older adults, the mechanisms behind the development of the disease aren't well understood, and at present the only therapeutic option is valve replacement. Valvular interstitial cells (VICs) may hold the answer. These cel...

詳細記述

書誌詳細
出版年:PLoS ONE
主要な著者: Marcus Ground, Steve Waqanivavalagi, Young-Eun Park, Karen Callon, Robert Walker, Paget Milsom, Jillian Cornish
フォーマット: 論文
言語:英語
出版事項: Public Library of Science (PLoS) 2022-01-01
オンライン・アクセス:https://doi.org/10.1371/journal.pone.0270227

類似資料